AVALYN PHARMA

avalyn-pharma-logo

Avalyn Pharma is a biopharma company that advances therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other severe respiratory diseases. Its therapies rapidly advance AP01 for the treatment of IPF, provides additional pipeline candidates for IPF, improve the care and outcomes of severe respiratory diseases, and develop novel inhaled therapeutics. Avalyn Pharma was established in 2011 and is headquartered in Seattle, Washington.

#SimilarOrganizations #People #Financial #Website #More

AVALYN PHARMA

Industry:
Biopharma Biotechnology Medical Pharmaceutical

Founded:
2011-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.avalynpharma.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
97.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Euro Microsoft Exchange Online


Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

nmd-pharma-logo

NMD Pharma

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

Current Employees Featured

not_available_image

Mark W. Surber
Mark W. Surber Founder & CSO @ Avalyn Pharma
Founder & CSO

marc-schneebaum_image

Marc Schneebaum
Marc Schneebaum Chief Financial Officer @ Avalyn Pharma
Chief Financial Officer
2021-09-01

bruce-montgomery_image

Bruce Montgomery
Bruce Montgomery CEO @ Avalyn Pharma
CEO
2017-03-01

Founder


not_available_image

Mark W. Surber

Investors List

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series B - Avalyn Pharma

norwest-venture-partners_image

Norwest Venture Partners

Norwest Venture Partners investment in Series B - Avalyn Pharma

rivervest_image

RiverVest

RiverVest investment in Series B - Avalyn Pharma

tpg-biotech_image

TPG Biotech

TPG Biotech investment in Series B - Avalyn Pharma

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series B - Avalyn Pharma

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series B - Avalyn Pharma

edmond-de-rothschild-private-equity_image

Edmond de Rothschild Private Equity

Edmond de Rothschild Private Equity investment in Series A - Avalyn Pharma

edmond-de-rothschild-investment-partners_image

Andera Partners

Andera Partners investment in Series A - Avalyn Pharma

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Avalyn Pharma

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series A - Avalyn Pharma

Official Site Inspections

http://www.avalynpharma.com

  • Host name: 170.251.121.34.bc.googleusercontent.com
  • IP address: 34.121.251.170
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Avalyn Pharma" on Search Engine